Tommy Chong Video #3 RFMK CANNAcig : "Loving Shelby"

New Post Public Reply Private Reply Replies (1) Message Board
CherylShuman

Tommy Chong Video #3 RFMK CANNAcig :

"Loving Shelby" Tommy speaks about loving his beautiful wife Shelby and their decades long successful marriage.

http://www.youtube.com/watch?v=icljm-qhLGc

http://www.youtube.com/watch?v=4rG3wGf0MJ4

Just wait until you see the additional segments of the interview to come. ESPECIALLY the one where he tries the CANNAcig by RFMK  I'm sure that there are quite a few people waiting to hear/see that one!


Thoughts anyone?

Published on  Aug 6, 2012 by 

Interview Exclusive By Cheryl Shuman:
I met Tommy Chong back in the 90's when he was starring on "That 70's Show". Ironically, we shared the same publicist who arranged a visit to the set to meet Ashton Kutcher and the rest of the cast. His beautiful wife Shelby was on the set with him that day. We have stayed in touch ever since. 

We reunited when I launched the Beverly Hills Chapter of NORML in 2009. Tommy Chong and Cheech Marin both supported us by co-branding and launching their first concert film in decades with the Weinstein Company. The collaboration was an amazing success. 

Tommy Chong and I connected again when he says he is battling prostate cancer the best way he knows how: with medical cannabis.

"Cannabis is a cure," he told CNN in announcing his illness. The veteran comic, 74, said he was diagnosed last month but first noticed symptoms during his 2003-04 incarceration in California for selling pot paraphernalia. He described the cancer as a slow stage 1.

A longtime supporter of medicinal marijuana, Chong was giving an interview about the health benefits of pot when he revealed his illness. "I've got prostate cancer, and I'm treating it with cannabis oil," he told CNN's Don Lemon. "So [legalizing marijuana] means a lot more to me than just being able to smoke a joint without being arrested."

Chong told the cable news network he quit smoking marijuana last year "for health reasons" but is using cannabis oil to treat the disease. "[I take it] at night, so I won't be woozy all day," he said. "I'm taking it as a medicine."

A native of Edmonton, Alberta, Chong rose to fame during the early 1970s with partner Richard "Cheech" Marin as the stoner-comedy duo Cheech and Chong. They released eight albums from 1971-85, three of which hit the top 10, and won a best comedy recording Grammy for 1973's Los Cochinos. The pair also co-wrote and starred in eight films, starting with the 1978 stoner classic Up in Smoke.

Cheech and Chong also toured as a comedy act but broke up during the mid-'80s after years of squabbling. They reunited in 2008 for the Cheech and Chong Light Up America stand-up tour, which resulted in the 2010 documentary Hey Watch This.

During a news conference at the Troubadour in West Hollywood -- where the duo was discovered in 1970 by producer Lou Adler -- to announce the reunion tour, Chong took time to praise the medicinal benefits of marijuana. Then he jokingly credited pot for "all of my youthfulness, my ... uh ..." -- "Memory," Marin chimed in with a grin.

In this exclusive interview series, Tommy discusses how "Cheech & Chong" was born all the way through their incredible film career, break up, Operation Pipe Dreams, prison, his cancer diagnosis and treating his cancer with cannabis. 


Total: 4 min 30 sec
Video Clip #2

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DayOne's Bold Energy Moves With Sembcorp for Asia Growth

Updated Category News Views 79

It seems the digital world and power supply have locked in a new dance as DayOne Data Centers teams up with Sembcorp Utilities. It's high time we gave this story a solid look, especially with data centers gobbling energy faster than my old trading partner downs an espresso. Tackling Energy Constraints Head-On The digital infrastructure beast is hungry for power, and...

Continue Reading
Jack Henry's Q1 2027 Deconversion Revenue Hits $17.9M

Updated Category News Views 30

Jack Henry Surprises with Strong Deconversion Revenue You're probably thinking, deconversion revenue—what on earth is that? Imagine you're in the financial tech business and one of your bigwig clients decides to merge or get gobbled up by another institution. They move shop, and voila, you've got some unexpected money flowing in due to that exit. That's deconversion...

Continue Reading
Young Leaders Drive Be Strong’s Mental Health Movement

Updated Category News Views 50

New Voices at the Helm Today’s youth aren’t just tomorrow's leaders; they’re stepping up now. Groups like Be Strong’s newly minted National Student Advisory Board are proving that. Sixteen kids across eleven states are diving headfirst into transforming mental health narratives. This ain't just some school club. These young guns are gearing up to reshape how we...

Continue Reading
Spotting Alzheimer's: Holiday Visits Might Reveal More

Updated Category News Views 34

The Unspoken Truth of Holiday Reunions Is there any better barometer than a holiday visit to gauge how your parents are truly doing? Most of us are zooming in, lugging our baggage through the front door and finding Dad telling the same old story not once, not twice, but three solid times at the table. Then there’s Mom, fumbling her way through that pie recipe she could...

Continue Reading
Yale's $10M Inflammation Initiative: Future Health Impact

Updated Category News Views 45

Yale’s Inflammation Research: Beyond the Basics Inflammation. It’s the kind of battle your own body wages from within, and Yale School of Medicine’s fresh $10 million grant from the Blavatnik Family Foundation means they’re marching deeper into the trenches. This is not another academic exercise; it’s about digging out the roots of diseases that are tough to pin...

Continue Reading
CloudKeeper Simplifies AI Cost Tracking with FinOps Launch

Updated Category News Views 43

AI Cost Management: A Complex Endeavor Tracking the myriad costs of AI operations can be downright infuriating. Every company dipping its toes in these waters quickly finds itself tangled in a web of fees spanning different models, applications, and cloud services. This tangled mess is about to get some much-needed untangling, thanks to CloudKeeper's latest move. They're...

Continue Reading
Quanta Services Reports Record Q3 2026 Earnings

Updated Category News Views 79

Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...

Continue Reading
Wabi's $1.25B Valuation: A New Era for AI?

Updated Category News Views 155

A Major Milestone for Wabi Well, here we go—Wabi, the brainchild of Eugenia Kuyda, is stirring the pot with a massive $55 million funding round, pulling its valuation up to a hefty $1.25 billion. If you're raising eyebrows at that price tag, you’re not alone. It's a big number riding on an even bigger idea: that AI isn't just for solitary chats anymore, but for...

Continue Reading
ACTEC Welcomes 55 New Fellows: A Closer Look

Updated Category News Views 99

Coffee's brewing hot, and so are the stakes at ACTEC, where 55 new Fellows just got the nod. The American College of Trust and Estate Counsel isn't your average club. They've been at this game since 1949, bringing together the finest minds in trusts and estates. But what does this newest batch bring to the table, and why should investors take a moment to notice? A Diverse...

Continue Reading
Static Media Acquires CarScoops to Boost Auto Reach

Updated Category News Views 74

Static Media's Latest Move in the Automotive Arena The digital media landscape keeps morphing, and Static Media just decided to crank up the gears a notch by snapping up CarScoops.com. For those with an eye on the automotive field, it's the kind of play that could shift the tides. Static Media, already a heavyweight with brands like Jalopnik and SlashGear under its belt,...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Action Against Jetstar for Misleading Passenger Rights

Updated Category News Views 207

Legal Action Against Jetstar for Misleading Passenger Rights New Zealand's competition authority is taking serious action against Jetstar, a low-cost airline operating under Qantas. They're in court over allegations that Jetstar misled its passengers about their rights to compensation due to delayed and cancelled flights. Allegations of Misleading Practices The New...

Continue Reading
Loona Petbot Commemorates Anniversary with User Engagement Surge

Updated Category News Views 197

Loona Petbot Commemorates Anniversary with Impressive User Engagement KEYi Technology is excited to share the remarkable success of its 1000-day anniversary celebration of the Loona Petbot. This event commenced recently and received an overwhelming response from users around the world. More than ten thousand participants engaged in the celebrations, showcasing the growing...

Continue Reading
Exploring Royce Small-Cap Trust: Current Insights and Trends

Updated Category News Views 145

Introduction to Royce Small-Cap Trust Royce Small-Cap Trust (NYSE: RVT) stands as a prominent name in the small-cap investment landscape, renowned for its commitment to long-term capital growth. Established as one of the oldest and largest closed-end funds focused on small-cap and micro-cap securities, this trust has carved a niche for itself among investors seeking...

Continue Reading
Grace Hill Teams with IWBI to Advance WELL Workspaces

Updated Category News Views 8

Pushing the Boundaries of Building Health The workplace is evolving, pal, and it ain't the stodgy cubicle farm it once was. Grace Hill, the technological maestro of real estate performance solutions, has shaken hands with the International WELL Building Institute (IWBI). This move ain't just about pushing a few papers but about bringing the occupant experience front and...

Continue Reading
Oppenheimer Upholds Outperform Rating for Tarsus Pharmaceuticals

Updated Category News Views 63

Oppenheimer Reaffirms Positive Outlook on Tarsus Pharmaceuticals Recently, Oppenheimer reiterated its favorable stance on Tarsus Pharmaceuticals (NASDAQ:TARS), affirming an Outperform rating coupled with a price target of $63. This endorsement comes ahead of the company's anticipated financial report for the third quarter of 2024, with special attention on the performance...

Continue Reading